top of page
News, Events and Updates
Search
ANAVEX Appoints Dr. Hervé de Kegrohen as CEO to Lead Company Through Clinical Trials & Future Growth
Jun 16, 2009
Pharmawire: Medivation, Anavex May Lower Oxidative Stress
Apr 8, 2009
Anavex Appoints Leading Alzheimer’s Disease Expert Dr. Mark Smith to Scientific Advisory Board
Feb 10, 2009
Anavex Scales Up Synthesis of ANAVEX 2-73 for Phase 1 Alzheimer’s Disease Study
Jan 30, 2009
Ground-Breaking Anti-Amnesic and Neuroprotective Effects of Alzheimer’s Compound ANAVEX 1-41
Dec 17, 2008
Anavex Presents Potent Neuroprotective Effects of ANAVEX 1-41 at Neuroscience 2008
Dec 4, 2008
Anavex Completes Successful Preclinical Studies on Lead Alzheimer’s Drug Candidate
Sep 2, 2008
Anavex Presents Neuroprotective Effects of ANAVEX 1-41 at the International Conference on AD 2008
Jul 30, 2008
Anavex Life Sciences Corp. Will Present New Findings at the International Conference on AD 2008
Jun 24, 2008
Anavex Further Strengthens Board of Directors
Jun 3, 2008
Anavex Announces Appointment of Oncology Specialist to Board of Directors
May 21, 2008
46
47
48
49
50
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
